107 related articles for article (PubMed ID: 23849986)
21. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
22. F-18 FDG PET/CT in the management of thyroid cancer.
Iagaru A; Kalinyak JE; McDougall IR
Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
24. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
25. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
[TBL] [Abstract][Full Text] [Related]
26. Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia.
Koh KC; Slavin MA; Thursky KA; Lau E; Hicks RJ; Drummond E; Wong PS; Worth LJ
Leuk Lymphoma; 2012 Oct; 53(10):1889-95. PubMed ID: 22448920
[TBL] [Abstract][Full Text] [Related]
27. ¹⁸F-FDG-PET/CT Imaging in Patients with Febrile Neutropenia and Haematological Malignancies.
Camus V; Edet-Sanson A; Bubenheim M; Hitzel A; Becker S; David M; Stamatoullas A; Lenain P; Jardin F; Contentin N; Fontoura ML; Cardinael N; Vaudaux S; Dubois S; Tilly H; Vera P; Leprêtre S
Anticancer Res; 2015 May; 35(5):2999-3005. PubMed ID: 25964587
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation.
Vos FJ; Donnelly JP; Oyen WJ; Kullberg BJ; Bleeker-Rovers CP; Blijlevens NM
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):120-8. PubMed ID: 21947022
[TBL] [Abstract][Full Text] [Related]
29. Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients.
Guy SD; Tramontana AR; Worth LJ; Lau E; Hicks RJ; Seymour JF; Thursky KA; Slavin MA
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1348-55. PubMed ID: 22584486
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report.
Tibúrcio FR; de Sá Rodrigues KE; Vasconcelos HM; Miranda DM; Simões e Silva AC
BMC Pediatr; 2015 Sep; 15():108. PubMed ID: 26337867
[TBL] [Abstract][Full Text] [Related]
31. The use of FDG-PET/CT in patients with febrile neutropenia.
Vos FJ; Bleeker-Rovers CP; Oyen WJ
Semin Nucl Med; 2013 Sep; 43(5):340-8. PubMed ID: 23905616
[TBL] [Abstract][Full Text] [Related]
32. FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia.
Hess S
PET Clin; 2020 Apr; 15(2):175-185. PubMed ID: 32145888
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary MRI--a new approach for the evaluation of febrile neutropenic patients with malignancies.
Rieger C; Herzog P; Eibel R; Fiegl M; Ostermann H
Support Care Cancer; 2008 Jun; 16(6):599-606. PubMed ID: 17943326
[TBL] [Abstract][Full Text] [Related]
34. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies?
Agrawal AK; Saini N; Gildengorin G; Feusner JH
Pediatr Blood Cancer; 2011 Oct; 57(4):620-4. PubMed ID: 21265012
[TBL] [Abstract][Full Text] [Related]
35. Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray.
Rámila E; Sureda A; Martino R; Santamaría A; Franquet T; Puzo C; Montesinos J; Perea G; Sierra J
Haematologica; 2000 Sep; 85(9):961-6. PubMed ID: 10980635
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of
Gutiérrez-Villanueva A; Quintana-Reyes C; Martínez de Antonio E; Rodríguez-Alfonso B; Velásquez K; de la Iglesia A; Bautista G; Escudero-Gómez C; Duarte R; Fernández-Cruz A
Microorganisms; 2024 Jan; 12(2):. PubMed ID: 38399711
[TBL] [Abstract][Full Text] [Related]
37. FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia.
Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
Leuk Lymphoma; 2019 Oct; 60(10):2471-2476. PubMed ID: 30947578
[TBL] [Abstract][Full Text] [Related]
38. Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET).
Bleeker-Rovers CP; Vos FJ; van der Graaf WT; Oyen WJ
Oncologist; 2011; 16(7):980-91. PubMed ID: 21680576
[TBL] [Abstract][Full Text] [Related]
39. Mold colonization of fiberglass insulation of the air distribution system: effects on patients with hematological malignancies.
Takuma T; Okada K; Yamagata A; Shimono N; Niki Y
Med Mycol; 2011 Feb; 49(2):150-6. PubMed ID: 20807030
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of higher plasma interleukin-6 levels in patients with febrile neutropenia.
Karan MA
Arch Med Res; 2002; 33(6):557-61. PubMed ID: 12505102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
